Asset Advisors Corp cut its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 50.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,715 shares of the healthcare conglomerate’s stock after selling 15,130 shares during the quarter. Asset Advisors Corp’s holdings in UnitedHealth Group were worth $2,882,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Harbour Capital Advisors LLC raised its position in UnitedHealth Group by 18,383.4% during the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after acquiring an additional 2,503,090 shares in the last quarter. Janus Henderson Group PLC grew its holdings in UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares during the last quarter. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares during the last quarter. Parametric Portfolio Associates LLC grew its holdings in UnitedHealth Group by 77.3% during the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares during the last quarter. Finally, Jennison Associates LLC grew its holdings in UnitedHealth Group by 180.4% during the second quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock valued at $417,660,000 after purchasing an additional 1,449,130 shares during the last quarter. 86.01% of the stock is owned by institutional investors.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares in the company, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock valued at $7,669,416 over the last quarter. 0.89% of the stock is owned by insiders.
UnitedHealth Group Inc (NYSE UNH) traded up $1.19 during trading on Thursday, hitting $225.39. The stock had a trading volume of 2,540,000 shares, compared to its average volume of 2,960,000. The firm has a market cap of $217,920.00, a price-to-earnings ratio of 25.61, a P/E/G ratio of 1.57 and a beta of 0.66. UnitedHealth Group Inc has a 52 week low of $156.09 and a 52 week high of $231.77. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.17 EPS. equities research analysts expect that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were given a $0.75 dividend. The ex-dividend date was Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.33%. UnitedHealth Group’s dividend payout ratio is presently 34.09%.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2018/01/11/unitedhealth-group-incorporated-unh-stake-lessened-by-asset-advisors-corp.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.